Pre Next

PDF Download

[1] GUO Dajiang YANG Haiying WU Huili ZHANG Jinxia,.Invigorating spleen，Tonifying kidney and RemovingTurbidity in Treatment of Obesity Related Nephropathy [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2022, (04): 42-45. [doi: 10.13424/j.cnki.jsctcm.2022.04.009]

Copy

Invigorating spleen，Tonifying kidney and RemovingTurbidity in Treatment of Obesity Related Nephropathy

Journal of Shaanxi University of Traditional Chinese Medicine[ISSN: 2096-1340/ CN: 61-1501/R] Volumes & Issues: 2022 04 pagination: 42-45 Column: Publication date: 2022-07-20

Article number:: 2096-1340(2022)04-0042-04

Author(s):: GUO Dajiang¹ YANG Haiying² WU Huili¹ ZHANG Jinxia ¹; 1.Qian’an Hospital of Traditional Chinese Medicine,Hebei Qian’an 064400,China ；
2.Qian’an people’s Hospital，Hebei Qian’an 064400，China

Keywords:: Key words：Invigorating Spleen and kidney; Resolving phlegm and reducing turbidity; Obesity associated nephropathy; Combination of acupuncture and medicine

ZTFLH:: R58

DOI:: 10.13424/j.cnki.jsctcm.2022.04.009

Code:: A

Abstract:: Abstract： Obesity has become a recognized global epidemic，and the incidence rate of obesity related diseases is also on the rise. The application of modified Jiangsheng powder in the treatment of early patients with the disease has achieved certain results in weight control and improvement of clinical symptoms，but it has been difficult to achieve satisfactory results in the reduction of a large number of proteinuria. In the process of reading classics and doing clinical work，we changed our thinking and applied the method of invigorating the spleen，tonifying the kidney and removing turbidity to treat obesity related nephropathy，which achieved good results in reducing weight and improving clinical symptoms，and made new achievements in reducing urinary protein leakage.

References:

［1］Weisinger JR，Kempson RL，Eldridge FL，el al.The nephrotic syndrome a complieation of massive obesity［J］.Ann Intern Med,1974,81(4):4400-447.
［2］王庆文.肥胖相关性肾病的临床表现［J］.肾脏病与透析肾移植杂志,2005,14(4):343-344.
［3］Chagnac A,Weinstein T,Herman M,et al.The effects of weight loss on renal function in patients with severe obesity［J］.Journal of the American Society of Nephrology,2003,14(6):1480-1486.
［4］胡伟新.肥胖相关性肾病的治疗［J］.肾脏病与透析肾移植杂志,2005,14(4):339-340.
［5］马爱景,冯梅,钟慧,等.肥胖相关性肾病［J］.西部医学,2006,18(2):207-209.
［6］刘成福,王小琴,范为民,等.从脾肾论治肥胖相关性肾病［J］.中西医结合研究,2012,4(5):268-270.
［7］田力铭,王兴,郝玉杰,等.健脾安肾方联合针刺治疗肥胖相关性肾病34例临床观察［J］.中医杂志,2015,56(14):1216-1219.
［8］汪泓，秦黎虹，马文明.浅议中医诊治肥胖［J］.中国中医药现代远程教育，2011,9（8）：111-112.
［9］龚海洋,张惠敏,王睿林,等.古代医家对肥胖的认识［J］.北京中医,2004,23(6):336-338.
［10］田建华,赵高明,蔡学兵.135例成人单纯性肥胖的中医辨证［J］.光明中医,2008,23(5):644-647.
［11］陈慧萍，肥胖相关性肾病的病理诊断［J］.肾脏病与透析肾移植杂志，2005,14（4）：341-342.
［12］高学敏.中药学［M］.北京:中国医药科技出版社,1990.
［13］程玥,陈淑娴,张雪,等.姜黄素对2型糖尿病肾病大鼠肾脏的保护作用［J］.陕西中医,2015,36(1):115-117.
［14］芦琨,尤丽菊,沈永杰,等.姜黄素对糖尿病肾病大鼠肾脏的保护作用及机制［J］.细胞与分子免疫学杂志,2015,31(8):1100-1102.
［15］陈才铭,张苗苗,胡利明.大黄酸对肥胖糖尿病大鼠肾皮质PPARγ和TGFβ1表达的影响［J］.中药材,2015,38(4):810-812.
［16］王铁云,周志强.腹针治疗单纯性肥胖临床疗效观察及其机制探讨［J］.基层医学论坛,2012,16(2):244-245.
［17］魏群利.针刺对肥胖大鼠脑干中缝核群单胺类神经递质作用的研究［J］.中国针灸,2002,22(5):331-333.
［18］杨春壮,孙世晓,刘长发,等.针刺对单纯性肥胖大鼠体重及血脂的影响［J］.针灸临床杂志,2006,22(12):58-59.
［19］马英,杨春壮,孙成,等.针刺对单纯性肥胖大鼠体重及下丘脑NO含量的影响［J］.牡丹江医学院学报,2007,28(4):10-12.

Memo

基金项目：第四批全国中医（临床、基础）优秀人才研修项目［国中医药人教发（2017）24号］

Last Update: 2022-07-25